Tibial or hip BMD predict clinical fracture risk equally well: results from a prospective study in 700 elderly Swiss women by Popp, A W et al.
ORIGINAL ARTICLE
Tibial or hip BMD predict clinical fracture risk equally well:
results from a prospective study in 700 elderly Swiss women
A. W. Popp & C. Senn & O. Franta & M. A. Krieg &
R. Perrelet & K. Lippuner
Received: 7 August 2008 /Accepted: 7 November 2008 /Published online: 19 December 2008
# International Osteoporosis Foundation and National Osteoporosis Foundation 2008
Abstract
Summary In a randomly selected cohort of Swiss community-
dwelling elderly women prospectively followed up for 2.8±
0.6 years, clinical fractures were assessed twice yearly. Bone
mineral density (BMD) measured at tibial diaphysis (T-DIA)
and tibial epiphysis (T-EPI) using dual-energy X-ray absorp-
tiometry (DXA) was shown to be a valid alternative to lumbar
spine or hip BMD in predicting fractures.
Introduction A study was carried out to determine whether
BMD measurement at the distal tibia sites of T-EPI and T-
DIA is predictive of clinical fracture risk.
Methods In a predefined representative cohort of Swiss
community-dwelling elderly women aged 70–80 years
included in the prospective, multi-centre Swiss Evaluation
of the Methods of Measurement of Osteoporotic Fracture
risk (SEMOF) study, fracture risk profile was assessed and
BMD measured at the lumbar spine (LS), hip (HIP) and
tibia (T-DIA and T-EPI) using DXA. Thereafter, clinical
fractures were reported in a bi-yearly questionnaire.
Results During 1,786 women-years of follow-up, 68 clinical
fragility fractures occurred in 61 women. Older age and
previous fracture were identified as risk factors for the
present fractures. A decrease of 1 standard deviation in BMD
values yielded a 1.5-fold (HIP) to 1.8-fold (T-EPI) signifi-
cant increase in clinical fragility fracture hazard ratio
(adjusted for age and previous fracture). All measured sites
had comparable performance for fracture prediction (area
under the curve range from 0.63 [LS] to 0.68 [T-EPI]).
Conclusion Fracture risk prediction with BMD measure-
ments at T-DIA and T-EPI is a valid alternative to BMD
measurements at LS or HIP for patients in whom these sites
cannot be accessed for clinical, technical or practical
reasons.
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Introduction
Bone mineral density (BMD) measurements by dual-energy
X-ray absorptiometry (DXA) are established worldwide as
the standard examination for identification of patients with
low bone mass and for monitoring BMD changes during
therapy with bone active substances. Low BMD values are
predictive of individual fracture risk. However, whilst this
has been clearly established for central measurement sites
of the skeleton, i.e. hip, lumbar spine and one third radius,
to some extent [1], less is known with regard to other
peripheral measurement sites, such as the tibia.
The tibia is a weight-bearing bone, easily accessible for
peripheral BMD measurements of its distal third. Peripheral
BMD measurements are of particular interest in elderly
patients in whom artefacts, e.g. due to osteoarthritis, may
preempt the diagnosis of low bone mass from the central
skeletal sites, and even more so if the stringent criteria of
BMD determination of the International Society for Clinical
Densitometry (ISCD) are applied, such as the sequential
exclusion of anatomically abnormal vertebrae [1]. They are
also of interest in patients with metabolic bone diseases or
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with specific forms of osteoporosis affecting the weight-
bearing bones, such as immobilisation osteoporosis in
paraplegics.
Whereas the tibial epiphysis (T-EPI) predominantly
consists of trabecular bone, tibial diaphysis (T-DIA)
predominantly contains cortical bone. Earlier research in
postmenopausal women and in women with primary
hyperparathyroidism showed that BMD measurements at
T-EPI and T-DIA were suitable for assessing bone loss and
bone mass distribution between the trabecular and cortical
compartments and for discriminating between the two with
high precision and reproducibility [2]. Furthermore, in
patients with immobilisation osteoporosis after spinal cord
injury (SCI), BMD was shown to decrease over time at
infralesional measurement sites including the tibia but not
at supralesional sites, such as the distal forearm [3]. In
addition, tibial bone loss after SCI was shown to be
significantly reduced by alendronate treatment over 2 years,
at both T-EPI and T-DIA, indicating that treatment effects
might be monitored by regular BMD measurement at the
distal third of the tibia [4]. Whether BMD measured at T-
EPI and T-DIA is predictive of fracture risk remains
unknown.
The aim of the present study was to determine whether
BMD measurement at the distal tibia sites of T-EPI and T-
DIA is predictive of clinical fracture risk.
Materials and methods
Population
In a predefined cohort of elderly (70 to 80 years old)
women who were included in the previously published
prospective, multi-centre Swiss Evaluation of the Methods
of Measurement of Osteoporotic Fracture risk (SEMOF)
study [5], BMD was measured using DXA. Women were
randomly recruited from official state registries between
January 1998 and April 2000 and were included in SEMOF
if able to walk and being independent for their daily
activities. Women with a history of hip fracture or of
bilateral hip replacement were not admitted. Those who
decided to attend their visit at the SEMOF site of the
Osteoporosis Policlinic of the University Hospital of Bern,
Switzerland were included in the present study.
Questionnaires and BMD measurements
At baseline, patient history was collected in a face-to-face
interview, including personal history of non-vertebral frac-
ture, maternal history of hip fracture, age at menopause, use
of oestrogens and/or corticosteroids, past and present
smoking and alcohol intake habits, past and present
osteoporosis treatment and propensity to falls. In addition,
a clinical examination was carried out. Weight was measured
on a standard beam scale without shoes and heavy outer
clothing and height was determined using the average of two
consecutive measurements using a Harpenden™ stadiometer.
Furthermore, a chair test (ability to stand up three times from a
chair without using the arms) was performed to assess the
participant’s propensity to falls [6].
BMD was measured at the lumbar spine (LS, first to
fourth lumbar vertebrae) and at the non-dominant (non-
fractured) total hip (HIP), femoral neck (NECK), trochanter
(TROCH), distal tibial diaphysis (T-DIA) and distal tibial
epiphysis (T-EPI) using DXA (Hologic QDR 4500A™,
Hologic, Bedford, MA, USA). Scans were performed
according to the manufacturer’s guidelines. The stand-
ardised procedure of tibial measurements was published
earlier by our group [2]. Briefly, the region of interest (ROI)
is defined as the area of 120 mm height and 129 mm width,
starting 10 mm above the top of the ankle joint space. T-
EPI corresponds to the distal 40 mm of the ROI and T-DIA
to the proximal 40 mm of this ROI. For repeated
longitudinal measurements, mean precision error of this
method was 1.4% and 2.1% for T-EPI and T-DIA,
respectively [2].
BMD was expressed as grams per square centimetre of
hydroxyapatite and as T-scores (standard deviation [SD]
from the mean of a healthy young female population).
Whereas the National Health and Nutrition Examination
Survey III (NHANES III) database [7–9] served as
reference for all hip sites, the manufacturer’s normative
database was used as reference for the lumbar spine after
analysis according to ISCD rules [1]. Thus, all evaluable
vertebrae from L1 to L4 were used. Vertebrae that were
affected by local structural changes or artefacts were
excluded from analysis if anatomically clearly abnormal
and non-assessable within the resolution of the system or if
the T-score difference with the adjacent vertebrae exceeded
1.0 SD. When vertebrae were excluded, BMD of the
remaining vertebrae was used to derive the T-score. Three
vertebrae were used if four could not, two were used if
three could not. Since BMD-based diagnostic classification
should not be made on a single vertebra, the lumbar spine
scan was judged non-evaluable in these cases.
For tibial BMD, the local Bern normative database
derived from 400 healthy Caucasian women living in the
area of Bern, Switzerland served as reference [10]. Peak
bone mass (mean value±SD of the age group 20 to 29 years)
in this female reference population is 1.278±0.116 g/cm2
(T-DIA), and 0.763±0.094 g/cm2 (T-EPI), respectively.
Quality control was performed daily (anthropometric
spine phantom supplied by the manufacturer) with an
overall precision error of 0.3% in vitro and a mean
precision error in our hands of 1.1% in vivo (LS).
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After the first and only mandatory visit, each patient
agreed returning a questionnaire every 6 months by mail,
registering any health changes, including any fracture that
occurred during the time interval between two question-
naires. For every fracture, the exact localisation and trauma
intensity were to be indicated. Low trauma or fragility
fractures were defined as either spontaneous or consecutive
to a fall from standing height or less. Each reported clinical
fracture was confirmed by a specific questionnaire
addressed either to the family practitioner or to the hospital
in charge of the participant, as requested by the patient.
Follow-up was completed in October 2002.
Statistics
After checking for normal distribution, results of all param-
eters were expressed as means and SD. Simple regression
analysis was applied to determine intersite correlations
between BMD at the various sites of measurement.
The hazard of the first clinical fracture was calculated by
using the proportional hazards model of Cox. For women
who experienced one or several clinical fractures, the
timespan between date of enrolment and date of the fracture
event was recorded. Hazard ratios (HR) are reported with
their corresponding 95% confidence intervals (95%CI).
They express the effect of a reduction of 1 SD in BMD at
each site, adjusted for significant predictors of clinical
fracture risk in this cohort, i.e. age (p=0.002) and previous
fracture (p=0.03) determined by Cox regression analysis.
The predictive value for clinical fracture risk of each
measurement site was determined by calculating the area
under the receiver operating characteristic (ROC) curve
using logistic regression. The differences between the areas
under the curves (AUCs) were tested by using the method
of DeLong et al. [11]. All analyses were performed with a
Stata 8.1 statistical software package (Stata, College
Station, TX, USA).
The primary goal of the SEMOF study was to evaluate
the potential of quantitative ultrasound devices for fracture
risk prediction. This study was mandated by the Federal
Office of Social Insurances and financed by the Association
of Swiss Health Insurances. A random sample of 56,561
Swiss women aged 70 to 80 years, generated by an
independent state office for addresses, the “Bureau vaudois
d’adresses”, was contacted by mail. In this sample, 7,562
women agreed being included in the study in one of the ten
participating osteoporosis centres, usually choosing the one
closest to their place of living. The sub-study with tibial and
other BMD measurements was initiated by the local
investigator from the Bern SEMOF site and sponsored by
the independent scientific fund of the Osteoporosis Poli-
clinic of the University Hospital and University of Bern.
The study protocol was accepted by the Swiss ethics
committee for medical sciences. All women gave their
written informed consent before inclusion.
Results
Seven hundred and one randomly selected women from the
region of Bern, 76.1±3.0 years old in average and with
mean BMI 25.8±4.1 kg/m2, were included in the study at
the SEMOF site of Bern. Of these, 14 women had no
baseline DXA measurement and another 50 (7.1%) were
lost for follow-up (i.e. did not return the first questionnaire
due 6 months after the inclusion visit). Drop-outs did not
differ significantly from participants remaining in the study
with regard to age, BMI and BMD at the various sites.
The remaining 637 women who were included in the
present study were (mean±SD) 76.0±3.0 years old with a
BMI of 25.8±4.3 kg/m2. The participants were followed up
during a mean observation period of 2.8±0.6 years (range
0.12 to 3.94 years), corresponding to a global follow-up of
1,786 women-years. During this follow-up, 68 clinical
fragility fractures occurred in 61 women. The fracture sites
were: forearm (n=25), vertebrae (n=13), proximal humerus
(n=12), hip and pelvis (n=8), ankle (n=4), elbow (n=2),
clavicle (n=1), rib (n=1), patella (n=1) and tibia (n=1).
Baseline demographics and detailed BMD values are
shown in Table 1. Compared to participants who did not
present a clinical fracture during the duration of the
observation, those who did were significantly older (76.9
vs. 75.9 years, p=0.02) and had more often a personal
history of fracture at baseline (66% vs. 51%, p=0.03).
However, clinical fracture patients did not significantly
differ from the remaining women with respect to maternal
history of hip fracture (6.8% vs. 11%, p = n.s.), current use
of oestrogens (5% vs. 12%, p = n.s.), current or past use of
corticosteroids (8% vs. 3.7%, p = n.s.), smoking (4.9% vs.
5.8%, p = n.s.), alcohol intake (31.5% vs. 39.7%, p = n.s.),
history of falls (one or more falls during the preceding year,
34% vs. 26%, p = n.s.), current or past osteoporosis therapy
(5% vs. 2.3%, p = n.s.) and feasibility of the chair test
(96.7% vs. 97.2%, p = n.s.).
Whereas all tibia and hip scans were evaluable, ISCD
rules led to the exclusion of 68 LS scans (i.e. >10% of all
LS scans). Participants with an incident clinical fracture had
significantly lower BMD at all measured sites compared to
those without (Table 1). The largest differences in mean T-
scores between the two groups were found at the LS (after
analysis according to ISCD, which reduced the number of
evaluable LS scans in the fracture group from 61 to 56) and
at both tibial sites. Fifty-three percent (30/56) of the women
with incident fractures had an initial T-score of −2.5 SD or
lower at the LS, 41% (25/61) at the NECK and 46% (28/
61) at the T-EPI, respectively. The respective specificities
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were 69% (LS), 78% (NECK) and 75% (T-EPI). If all three
sites were taken together, sensitivity increased to 69% (42/
61) whereas specificity decreased to 55%.
Table 2 shows the intersite correlations for BMD values
at the various sites. The correlation coefficients ranged from
0.499 (between T-DIA and L2–L4) to 0.905 (between
TROCH and HIP). The highest correlation between two
distinct bones was found between T-EPI and HIP with an r
value of 0.716.
As shown in Table 3, a decrease of 1 SD in BMD T-
score value yielded a 1.5-fold (HIP) to 1.8-fold (T-EPI)
significant increase of the clinical fragility fracture HR
(adjusted for age and previous fracture). The areas under
the ROC curves (AUC) were calculated in order to compare
the performance for clinical fracture risk prediction between
the individual measurement sites (Table 3). AUCs ranged
from 0.63 (LS) to 0.68 (T-EPI) with no significant differ-
ences between the sites measured.
Table 2 Intersite correlations (r) of BMD
Site LS (L2–L4) LS (L1–L4) ISCD T-score NECK TROCH HIP T-DIA
LS (L2–L4) 1.000
LS (L1–L4) 0.993 1.000
ISCD T-score 0.931 0.947 1.000
NECK 0.568 0.576 0.588 1.000
TROCH 0.608 0.618 0.619 0.765 1.000
HIP 0.622 0.631 0.640 0.862 0.905 1.000
T-DIA 0.499 0.510 0.528 0.509 0.558 0.644 1.000
T-EPI 0.577 0.588 0.610 0.608 0.677 0.716 0.781
Table 1 Demographic and BMD values at various sites of the 637 women who were available for follow-up examination (mean±SD)
Parameter All women (n=637) No clinical fracture (n=576) Clinical fracture (n=61) p value
Age (years) 76.0 (3.0) 75.9 (3.0) 76.9 (2.8) 0.02
Age at menopause (years) 49.1 (4.5) 49.1 (4.5) 48.3 (4.0) 0.2 (n.s.)
Weight (kg) 64.7 (10.9) 64.8 (10.9) 63.0 (11.1) 0.2 (n.s.)
BMI (kg/m2) 25.8 (4.3) 25.9 (4.2) 25.3 (4.5) 0.3 (n.s.)
Previous fracture (%) 52 51 66 0.03
Follow-up (days) 1,024 (233) 1,029 (227) 983 (275) 0.2 (n.s.)
LS
BMD L1–L4 (g/cm2) 0.898 (0.178) 0.906 (0.178)a 0.821 (0.170) 0.0004
BMD L2–L4 (g/cm2) 0.936 (0.007) 0.944 (0.187)b 0.858 (0.174) 0.0006
T-score ISCD (SD) −1.82 (1.40) −1.74 (1.38)c −2.53 (1.37)d <0.0001
HIP (NHANES)
BMD (g/cm2) 0.770 (0.121) 0.776 (0.119) 0.714 (0.123) 0.0001
T-score (SD) −1.42 (1.00) −1.37 (0.98) −1.88 (1.01) 0.0001
NECK
BMD (g/cm2) 0.653 (0.105) 0.658 (0.104) 0.600 (0.107) <0.0001
T-score (SD) −1.78 (0.95) −1.73 (0.94) −2.26 (0.97) <0.0001
TROCH
BMD (g/cm2) 0.587 (0.103) 0.592 (0.102) 0.539 (0.102) 0.0002
T-score (SD) −1.16 (1.03) −1.10 (1.02) −1.64 (1.02) 0.0001
T-DIA
BMD (g/cm2) 1.163 (0.156) 1.170 (0.154)e 1.093 (0.158) 0.0002
T-score (SD) −1.00 (1.35) −0.93 (1.33)e −1.63 (1.37) 0.0001
T-EPI
BMD (g/cm2) 0.599 (0.103) 0.606 (0.103)e 0.541 (0.089) <0.0001
T-score (SD) −1.73 (1.10) −1.67 (1.10)e −2.37 (0.95) <0.0001
a n=562
b n=568
c n=513
d n=56
e n=575
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Discussion
In the present predefined cohort of 701 elderly women, 687
had their BMD measured at the lumbar spine, hip, and tibial
epiphysis and diaphysis. They were prospectively followed
up during almost 3 years with regard to fracture events.
Each decrease in BMD of 1 SD resulted in a consistent
increase in clinical fracture HR ranging between 1.5 (for
tibial diaphysis, trochanter and total hip) and 1.8 (for tibial
epiphysis). There was no significant difference in predictive
value for clinical fractures between the different BMD
measurement sites. BMD measurement at the tibia (T-EPI
or T-DIA) can, therefore, be considered as being of similar
predictive value than BMD measurement at the lumbar
spine or the hip.
These findings are consistent with previously published
observations. In the meta-analysis of Marshall et al. [12],
including 11 studies with more than 90,000 person-years of
observation and more than 2,000 fractures, all measured
sites (limited to the spine, hip and radius) had similar
predictive ability for global fracture risk with a relative risk
(RR) of 1.4–1.6 per SD loss of BMD with the exceptions of
LS measurements for predicting vertebral fractures (RR=
2.3) and of hip measurements for predicting hip fractures
(RR=2.6). Interestingly, the predictive value of a 1 SD
decrease in BMD was shown to be comparable to that of a
1 SD increase in blood pressure for stroke and better than a
1 SD increase in serum cholesterol for cardiovascular
disease [12]. The National Osteoporosis Risk Assessment
(NORA) study reported similar results for heel, forearm and
finger BMD [13]. These findings were confirmed by the
10-year data of the Study of Osteoporotic Fractures (SOF),
which reported RR values around 1.4 for six different BMD
measurement sites (distal and proximal radius, heel, spine,
total hip and femoral neck) [14]. In the present study, the
adjusted HR for any clinical fracture attributed to a decrease
of 1 SD in BMD was 1.5 for T-DIA and 1.8 for T-EPI.
Tibial BMD measurement has been shown to be useful
in the context of immobilisation osteoporosis after spinal
cord injury [3–4]. However, it may also become important
in a variety of other clinical situations. In patients with
severe osteoarthritis of the spine or hip and in patients who
underwent hip or spine surgery, e.g. hip replacement or
scoliosis fixation/vertebroplasty, and have orthopaedic
implants, BMD must be measured at a peripheral site.
Furthermore, in the present study, the ISCD criteria applied
to lumbar spine BMD analysis resulted in a loss of almost
10% of all evaluable patients. There also, BMD measure-
ment at the tibia may be a suitable alternative. In patients
with metabolic bone diseases, such as hyperparathyroidism,
cortical bone loss is known to be more pronounced than
trabecular bone loss [15–16] and these patients are at
increased risk for fractures [17]. In dialysed renal insuffi-
ciency patients, earlier research has provided evidence for
the preservation of cortical bone (measured at T-DIA) with
continuous ambulatory peritoneal dialysis compared to
haemodialysis, possibly in relationship with the higher
residual renal function observed in the former [18].
Furthermore, in the very specific population of female to
male transsexuals under long-term hormonal treatment, the
effect of androgens on cortical bone was shown in a cross-
sectional study measuring BMD at the tibial sites [10]. In
idiopathic renal stone formers, BMD was previously shown
to be reduced at LS, Ward’s triangle, T-EPI and T-DIA,
whereby the latter two showed the largest magnitudes of
change [19]. Although the mechanism behind this possible
site selectivity remains unknown, this observation docu-
ments that tibial measurements may give access to not yet
understood pathophysiological mechanisms in specific
patient populations and/or metabolic bone diseases.
Table 3 Adjusted HR of clinical fractures attributed to a decrease of 1 SD in BMD and predictive power of BMD variables for clinical fracture
using the area under the ROC curves (AUC)
BMD variables N SE SD Coefficient HR (95%CI) AUC (95%CI)
Lumbar spine
L2–L4 629 0.73 0.188 2.37 1.6 (1.2, 2.0) 0.63 (0.56, 0.70)
L1–L4 623 0.78 0.178 2.59 1.6 (1.2, 2.1) 0.63 (0.56, 0.70)
ISCD T-score 569 0.10 1.399 0.39 1.7 (1.3, 2.3) 0.65 (0.58, 0.72)
Hip (Hologic–NHANES)
Neck 636 1.24 0.105 4.82 1.7 (1.3, 2.1) 0.65 (0.58, 0.72)
Trochanter 636 1.15 0.103 3.81 1.5 (1.2, 1.9) 0.64 (0.57, 0.72)
Total hip 636 0.99 0.121 3.44 1.5 (1.2, 1.9) 0.64 (0.56, 0.71)
Tibia
Tibial diaphysis BMD 636 0.82 0.156 2.74 1.5 (1.2, 2.0) 0.64 (0.57, 0.71)
Tibial epiphysis BMD 636 1.35 0.103 5.67 1.8 (1.4, 2.4) 0.68 (0.61, 0.74)
Adjusted for age and past fracture using Cox regression
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In the tibia, cortical (T-DIA) and predominantly trabec-
ular (T-EPI) bone regions can be measured within the same
weight-bearing bone, thereby reducing the potential for
differences in BMD related to different localisations in the
body. BMD measurement at the tibia does not only reflect
the distribution of bone loss in the two compartments [2],
but should now also be considered as predictive for clinical
fracture risk. Paraplegics are at increased fracture risk due
to the massive and sustained bone loss they experience in
their lower limbs. In paraplegic men, BMD at T-EPI and T-
DIAwas shown to follow a different decrease pattern, tibial
epiphysis showing a rapid demineralisation which levels off
3 years after SCI and comparable to observations made at
the femoral neck level and tibial diaphysis showing a
slower but continuous demineralisation which proceeds
even beyond 10 years post-injury. In contrast, no such bone
loss was observed at the supralesional BMD measurement
sites [3]. Based on the results of the present study and
others [4], BMD changes at the tibia may be considered as
predictive for fracture risk in this patient population.
According to the World Health Organisation and ISCD
guidelines, the diagnosis of osteoporosis should ideally be
made on the basis of a BMD measurement performed at the
femoral neck [1]. However, there are clinical situations in
which these recommended measurements are not practica-
ble, such as in patients after bilateral hip replacement (who
were excluded from the present study), patients with severe
osteophytosis due to hip osteoarthritis and patients with
restricted hip mobility due to severe pain. Although such
patients were excluded by protocol from the present study,
they represent a non-negligible and even reasonably sized
patient population in daily practice. For these patients, an
easily accessible peripheral measurement site with good
predictive value for overall clinical fracture risk is of
expected clinical interest in daily practice. In the present
study, the intersite correlations between BMD measured at
the femoral neck and T-DIA/T-EPI were 0.509/0.608,
respectively. These values were comparable to the correla-
tion coefficient observed between lumbar spine and femoral
neck. For all patients mentioned above, a BMD measure-
ment at T-DIA and T-EPI may, therefore, become a
valuable alternative or addition to a BMD measurement at
the lumbar spine or femoral neck for determining their
individual fracture risk. This may become especially
important in women aged 65 years and older, since the
increase in fracture risk prediction achieved by combining
BMD measurements at the lumbar spine and femoral neck
was shown to vanish due to degenerative changes of the
lumbar spine [20].
Among all risk factors for fracture assessed in the
present study, only age and personal history of fracture
were significantly different between fractured and non-
fractured patients. This contrasts with recent findings,
showing that risk factors such as smoking status, maternal
history of hip fracture and corticosteroid intake were
significant predictors of increased fracture risk [21].
However, these recent findings rely on a meta-analysis of
nine primary cohorts including more than 46,000 patients
and corresponding to almost 190,000 person-years of
observation to be compared with the modest 701 persons
during 1,786 women-years in the present study.
This study has several strengths: it was performed
longitudinally and prospectively in a random sample of
the elderly Swiss female population over a prolonged
period of time (almost 3 years) and had a very low dropout
rate (less than 8%). It does, however, have some limi-
tations. The low number of fractures precluded an evalu-
ation of the HR and AUCs by fracture type. Only clinical
fractures were reported, whether the same conclusions
would apply to morphometric vertebral fractures remains
unknown. Whether T-EPI would be more appropriate to
predict fracture risk at sites with high trabecular bone
contents (such as the trochanter or the spine) and whether
T-DIA would be more appropriate for fracture risk at
predominantly cortical sites could not be determined.
Furthermore, areas of future research should include the
study of the value of T-DIA and T-EPI BMD measurements
for treatment monitoring in patient populations where
changes in BMD are expected to be less dramatic than in
paraplegics, such as postmenopausal women treated with
bone active substances, and the study of the added value of
tibial BMD measurements combined to other measurement
sites, such as LS and HIP, in elderly patients.
In conclusion, fracture risk prediction with BMD
measurements at the peripheral tibial sites T-DIA and
T-EPI is a valid alternative to BMD measurements at the
lumbar spine and the hip for patients in whom these sites
cannot be accessed for clinical, technical or practical
reasons.
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